PharmRevise

How to revise for the GPhC registration assessment

A revision plan built on the documents the GPhC publishes about its own assessment, with a link to each. Checked on 3 October 2026.

PharmRevise is not affiliated with or endorsed by the General Pharmaceutical Council, and is not a source of official information about its assessment. For anything that decides your registration, go by the GPhC's own pages.

Start with the GPhC's own documents

Before you buy or download anything else, read what the GPhC publishes. Five documents tell you what the assessment covers and how it runs:

All five are on the GPhC's Sitting the Common Registration Assessment page. On 3 October 2026 the framework, specification and regulations were the versions "for sittings in 2026". If you sit in June 2027, check that page again for the 2027 versions.

GPhC: Common Registration Assessment, Sitting the Common Registration Assessment, framework for sittings in 2026 (PDF), specification and permitted items (PDF), example questions guide (PDF).

Know the shape of the assessment

The assessment has two parts. You need the pass mark or more in both parts at the same sitting. A strong Part 2 can't make up for a weak Part 1.

Once you have an account, the Mock paper on Home sets a timed Part 1 or Part 2 with the same number of questions and the same time as the real part, with no feedback until the end.

GPhC framework for sittings in 2026; specification and permitted items.

What carries the most weight

The GPhC doesn't publish a percentage for each topic. The framework says: "There is no fixed minimum or maximum number of questions assigned to each clinical therapeutic area". What it gives you instead is an order. The fifteen clinical areas are "ordered based on their prevalence in the assessment", from most often assessed to least:

  1. Cardiovascular
  2. Central nervous
  3. Endocrine
  4. Infection
  5. Gastro-intestinal
  6. Respiratory
  7. Musculoskeletal and joint diseases
  8. Nutrition and blood
  9. Malignant disease and immunosuppression
  10. Skin
  11. Eye
  12. Ear, nose and oropharynx
  13. Vaccines
  14. Drug toxicity
  15. Obstetrics, gynaecology and genito-urinary

Most Part 2 questions apply clinical knowledge to patient scenarios. The rest are on law, governance and regulation, which can also turn up inside calculation and clinical questions.

Two lists cut across every area. The first is the high-risk drug classes: anti-infectives, anti-thrombotics, chemotherapy, conventional DMARDs, corticosteroids, hypnotics and anxiolytics, immunosuppressants, insulins, narrow therapeutic index medicines and those needing drug monitoring, opioids, teratogenic medicines and time-critical medicines. The second is MHRA and Commission on Human Medicines safety alerts, which the GPhC expects you to keep up to date with.

Our suggestion, which is not a GPhC weighting: give your time roughly in the framework's order, and treat the high-risk classes as a second pass through every area.

GPhC framework for sittings in 2026.

Revise to apply, not to recall

The framework says the assessment "prioritises the assessment of a trainee pharmacist's ability to apply pharmacy knowledge and skills to relevant scenarios over factual recall". Questions put a medicine in front of a particular person. The framework names pregnancy, breastfeeding, older people, palliative and end-of-life care, renal or hepatic impairment, multiple conditions, and children. For each topic you revise, ask how the answer changes for each of those people.

Some questions come with a resource on screen, such as a BNF extract, an SmPC, a prescription, a medication administration record or a controlled drugs register. Practise finding information in those layouts quickly. Normal ranges for lab results are given, but normal ranges for common physiological measurements are not, and nor are common guidelines: the framework expects "a working knowledge" of them.

GPhC framework for sittings in 2026.

Calculations: little and often

Every Part 1 paper includes at least one of each of nine calculation types: concentrations, dilutions, displacement volumes, doses and dosage regimens, infusion rates, medical statistics, pharmacoeconomics, pharmacokinetics and quantities to supply. Every question takes more than one step. Simple formulae such as body mass index aren't given; more complex ones are. Doing a few questions most days builds speed better than a long session once a week. Our calculations guide works through one example of each type.

GPhC framework for sittings in 2026.

Use the June 2026 insights, carefully

After the June 2026 sitting, the Board of Assessors named areas where performance suggested more development was needed.

The Board says these insights "do not indicate that these topic areas are more likely to appear in future assessments". Read them as places where candidates tend to slip, not as a forecast.

GPhC Board of Assessors, Key insights from the June 2026 Common Registration Assessment (PDF).

Keep your sources current

Guidance changes, and revision material doesn't update itself. A question written a few years ago can teach a treatment step that NICE has since changed. Whatever you revise from, check when it was written and where each answer comes from. That applies to PharmRevise too. Our terms of use say a key that was right when it was written can become wrong, so check the source shown with each answer.

A plan to June 2027

The June 2027 assessment is on Tuesday 15 June 2027, and results are due on Tuesday 20 July 2027 (GPhC).

Sitting on Tuesday 10 November 2026 instead? Put the time into calculations under time and your weakest areas.

GPhC Sitting the Common Registration Assessment.

Where question banks fit

The Board of Assessors is plain about this: it does "not endorse external revision or preparation materials as these may differ in content, style and level of challenge compared to the actual assessment". That includes PharmRevise. The GPhC's own advice is that "the best preparation for the assessment comes from the experience gained during the foundation training year". Use any question bank as practice, and check its answers against their sources.

On PharmRevise, each written question names the source its answer key is based on, and most quote the passage. Calculation questions show a worked solution.

GPhC Board of Assessors, Key insights from the June 2026 Common Registration Assessment (PDF, p.1); GPhC Sitting the Common Registration Assessment.

Create a free account

Not affiliated with or endorsed by the General Pharmaceutical Council. A revision guide, not official information about the assessment, and not clinical advice. Quotations are from the GPhC's Common Registration Assessment framework for sittings in 2026, its Key insights from the June 2026 assessment, and its Sitting the Common Registration Assessment page, each linked above and checked 3 October 2026. See our terms of use and privacy notice.